OSCR
Oscar Health, Inc. Healthcare - Health Insurance Investor Relations →
Oscar Health, Inc. (OSCR) closed at $12.63 as of 2026-03-20, trading 8.2% above its 200-week moving average of $11.67. The stock is currently moving closer to the line, down from 13.7% last week. The 14-week RSI sits at 35, indicating neutral momentum.
Trading volume is running at 1.0x of its 14-week average, which is in the normal range. The balance between buying and selling volume (1.10 ratio) is neutral — neither side is clearly dominating.
Over the past 215 weeks of data, OSCR has crossed below its 200-week moving average 1 time. On average, these episodes lasted 100 weeks. The average one-year return after crossing below was -26.1%, suggesting these dips have not historically been reliable buying opportunities for this stock.
With a market cap of $3.8 billion, OSCR is a mid-cap stock. The company generates a free cash flow yield of 18.6%, which is notably high. Return on equity stands at -44.4%. The stock trades at 3.8x book value.
Share count has increased 37.6% over three years, indicating dilution.
Over the past 4.2 years, a hypothetical investment of $100 in OSCR would have grown to $177, compared to $158 for the S&P 500. That represents an annualized return of 14.7% vs 11.5% for the index — confirming OSCR as a market-beating investment and the kind of quality company where buying during 200-week moving average touches has historically been rewarded.
Free cash flow has been growing at a 44.4% compound annual rate, with 2 consecutive years of positive cash generation.
Business Health
Annual financials — how the underlying business has performed over the past several years.
Cash Flow Free cash flow & net income ($M)
Revenue Annual revenue ($M) — business growth proxy
Total Debt Balance sheet debt ($M)
ROIC Return on invested capital (%)
FCF Yield Free cash flow / market cap (%) — Yartseva signal
Gross Margin Pricing power & competitive moat (%)
Shares Outstanding Buybacks vs dilution (millions)
Growth of $100: OSCR vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After OSCR Crosses Below the Line?
Across 1 historical episodes, buying OSCR when it crossed below its 200-week moving average produced an average return of -30.0% after 12 months (median -30.0%), compared to -8.0% for the S&P 500 over the same periods. After 24 months, the average return was +133.0% vs +20.0% for the index.
Each line shows $100 invested at the moment OSCR crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Historical Touches
OSCR has crossed below its 200-week MA 1 time with an average 1-year return of +-26.1% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| Feb 2022 | Jan 2024 | 100 | 81.3% | -26.1% | +88.5% |
| Average | 100 | — | +-26.1% | — |
Frequently Asked Questions
Is OSCR below its 200-week moving average?
No. Oscar Health, Inc. (OSCR) is currently 8.2% above its 200-week moving average of $11.67. It would need to fall to $11.67 to cross below the line.
What is OSCR's 200-week moving average price?
Oscar Health, Inc.'s 200-week moving average is $11.67 as of 2026-03-20. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.
What happens when OSCR drops below its 200-week moving average?
OSCR has crossed below its 200-week moving average 1 time in our data. The average one-year return after these crossings was -26.1%, meaning the dips were not reliable buying signals for this particular stock. These episodes lasted 100 weeks on average.
Is OSCR a good value right now?
Here's what our data says about OSCR as of 2026-03-20: The stock is above its 200-week moving average, so it doesn't currently meet our primary signal. The 14-week RSI is 35. Free cash flow yield is 18.6%. Return on equity is -44.4%. Price-to-book is 3.8x. This is not a buy or sell recommendation — always do your own research.
How does OSCR compare to the S&P 500?
Over the past 4.2 years, $100 invested in OSCR would have grown to $177, compared to $158 for the S&P 500. That's 14.7% annualized vs 11.5% for the index. OSCR has outperformed the broader market over this period.
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of week of 2026-03-20